Stock listing

OTC:NSTM NovelStem International Corp. Stock

Follow NovelStem International Corp. into a list and get an email when it puts out news.

Share price · OTC:NSTM

$0.0070 USD -0.0030 (-30.0%)

Close on Nov 2, 2026

Past year -65.0% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.0070 – $0.0070 USDNov 2, 2026
Volume
188 sharesNov 2, 2026
Market cap
$345,327 USDAt the close on Nov 2, 2026 · price × 49.33M shares outstanding
52-week range
$0.0070 – $0.0357 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$158 USDMedian day 0 shares · 44 days with no trades · last 3 months, Aug 3, 2026 – Nov 2, 2026
NovelStem International Corp. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OTC:NSTM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0070-0.0030-30.0%$0.0070$0.0070$0.0070188
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.0100600
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.010011,900
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.0100126,400
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.0100175,000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.010045,000
$0.01000.00000.0%$0.0100$0.0100$0.0100200
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.010025,000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.0100800
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01009,000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01001,000
$0.01000.00000.0%$0.0100$0.0100$0.01001,300
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.0100129,900
$0.01000.00000.0%$0.0100$0.0100$0.0100387,500
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.010018,266
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.01000
$0.01000.00000.0%$0.0100$0.0100$0.010018,266
Ticker
OTC:NSTM
Asset type
Stock
Sector
Financials
Industry
Shell companies & SPACs
Exchange
OTC
Currency
USD

Latest news

NovelStem Announces Material Developments and Strategic Repositioning of the Company

May 20, 2025

NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd

Apr 11, 2022

NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

Feb 15, 2022

NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator

Sep 20, 2021

NovelStem Increases NewStem Ownership to 33% as NewStem Preps for 1H'21 FDA Filing for Approval of Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; Initiates Process to Be Publicly Reporting...

Dec 1, 2020

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy & COVID-19 Resistance; Progress ID'ing Genetic Resistance to Addt'l Anti-Cancer Treatments

Apr 21, 2020

NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic

Dec 16, 2019

NovelStem Provides Shareholder Update

May 8, 2019

Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies

Sep 25, 2018

NewStem Announces $4 million Seed Investment

Jul 16, 2018

Issued by another party

All NovelStem International Corp. news

NovelStem International Corp. on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
15 in all · newest May 20, 2025 · oldest 2014

Log in to ask 6ix AI your own questions about NovelStem International Corp.